Blog - Page 2 of 5734 - QualityStocks

FridaySep 11, 2026 10:30 am

Cheaper Drones Are Exposing a New Weakness in Counter-UAS Defense

The economics of drone warfare are changing rapidly, with inexpensive unmanned systems creating an increasingly difficult cost equation for traditional counter-UAS defenses. At the same time, fiber-optic-guided and autonomous drones can operate without the radio-frequency emissions that many conventional detection and jamming approaches depend on. Wrap Technologies Inc. (NASDAQ: WRAP) is addressing both challenges through WrapShield(TM), combining Frenel Imaging Ltd.’s physics-based sensing technology with laser-directed energy for counter-UAS applications. Drones have become an increasingly important tool in modern military operations, providing intelligence, surveillance and strike capabilities while reducing the need to put personnel directly in harm’s way. As these systems…

FridaySep 11, 2026 10:22 am

QualityStocksNewsBreaks – Nanox Imaging Ltd. (NASDAQ: NNOX) Signs Nanox.ARC Distribution Agreement for Costa Rica

Nanox (NASDAQ: NNOX) announced a distribution agreement with Costa Rica-based medical equipment distributor SOLME RC, S.A. to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. SOLME will oversee marketing, distribution, installation, training and ongoing technical support in Costa Rica, where it is a registered supplier to the Caja Costarricense de Seguro Social (“CCSS”), the country principal purchaser and provider of hospital services. Commercialization will follow applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration, and Costa Rica represents Nanox third Latin American market this year…

FridaySep 11, 2026 9:45 am

Greenland Mines Ltd. (NASDAQ: GRML) Key Points to Watch Include Rare Earths Closing, Drill Results and Growing AnorTech Stake

Completion of Sarfartoq acquisition announced following formal approval from Greenland government. The 2026 Skaergaard field season is now in its active phase and should generate results before the Arctic season ends. An updated Sarfartoq resource estimate is in progress, and AnorTech stake option is worth tracking closely. Every small-cap mining stock eventually reaches a stretch where several catalysts line up in close succession. That stretch turns a quiet chart into something worth watching closely. For Greenland Mines (NASDAQ: GRML) that stretch is now. Four items are converging: the close of its rare earths acquisition following government approval, the end of…

FridaySep 11, 2026 9:20 am

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Featured in BioMedWire Editorial on Lucid-MS Phase 2 Trial

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) announced its placement in a BioMedWire editorial examining the potential of Lucid-MS to address limitations of existing multiple sclerosis (“MS”) treatments. The editorial highlights Quantum BioPharma’s U.S. Food and Drug Administration (“FDA”) clearance to launch a phase 2 trial of Lucid-MS, a patented, first-in-class candidate designed to protect and potentially rebuild the myelin sheath rather than suppress the immune system. According to the publication, the trial would mark the first time a drug based on this mechanism is tested in people…

FridaySep 11, 2026 9:00 am

Regentis Biomaterials Ltd. (NYSE American: RGNT) Advances GelrinC as a Potential New Approach to Knee Cartilage Repair

Researchers across the field, from Duke University to Mayo Clinic, are increasingly focused on restoring damaged cartilage rather than simply managing the symptoms associated with its loss. Regentis Biomaterials’ GelrinC is designed to support the body’s natural cartilage-regeneration process through a gradual, controlled repair environment. Early clinical data has provided encouraging evidence for GelrinC, which already has approval in Europe, while an FDA-authorized pivotal trial is advancing its development toward potential U.S. approval. A knee that once carried a runner through marathons or a hiker up a steep mountainside can be sidelined by a single defect in cartilage. More broadly,…

ThursdaySep 10, 2026 1:06 pm

QualityStocksNewsBreaks – AmpliTech Group, Inc. (NASDAQ: AMPG, AMPGZ) Receives $7.3 Million in Follow-On Orders for Asian 5G O-RAN Deployment

AmpliTech Group (NASDAQ: AMPG, AMPGZ) received approximately $7.3 million in follow-on orders supporting deployments for an Asian mobile network operator (“MNO”) under its previously announced 5G O-RAN radio Letter of Intent (“LOI”) program. The orders follow deployment of AmpliTech O-RAN radios at end-customer 5G sites and represent renewed purchasing activity under the program. The company said the orders, together with recently received follow-on orders supporting its North American MNO program, restore momentum under the LOI program and support its efforts to convert its opportunity pipeline into shipments and revenue. To view the full press release, visit https://ibn.fm/p85ry About AmpliTech Group, Inc. AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGZ)…

ThursdaySep 10, 2026 1:05 pm

QualityStocksNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Bolsters Scientific Leadership Ahead of BiTAC(R) Clinical Development

VERAXA Biotech (NASDAQ: VRXA) recently appointed antibody therapeutics specialist Dr. Christoph Erkel as its chief scientific officer, taking responsibility for advancing the company’s proprietary BiTAC(R) technology and broader oncology pipeline toward clinical development. The company’s lead BiTAC-TCE program uses a conditionally active, dual-targeting approach designed to selectively activate T cells against cancer cells while potentially limiting effects on healthy tissue. Recent scientific advice from Germany’s Paul-Ehrlich-Institute provided additional clarity around the program’s proposed non-clinical development strategy, while preclinical data presented at the AACR Annual Meeting showed selective activity against cells expressing both target molecules. Beyond BiTAC, VERAXA is developing bispecific antibody-drug…

ThursdaySep 10, 2026 12:37 pm

QualityStocksNewsBreaks – Silver Bow Mining Corp. (NYSE American: SBMT) Receives Bankruptcy Court Approval, Completes Initial Closing for Jefferson County Metallurgical Complex

Silver Bow Mining (NYSE American: SBMT) announced that the U.S. Bankruptcy Court for the District of Montana approved the sale of specified Montana Tunnels Mining assets comprising the Jefferson County Metallurgical Complex to Silver Bow and its wholly owned subsidiary, Silver Bow Tunnels Corp. The company also completed the initial closing under its previously announced definitive asset purchase agreement after funding approximately $28.58 million into escrow to satisfy specified creditor obligations, including approximately $4.27 million owed to Jefferson County and $20.78 million in specified obligations to the Montana Department of Environmental Quality. The initial closing does not transfer ownership of the Complex to Silver Bow. The company…

ThursdaySep 10, 2026 12:24 pm

QualityStocksNewsBreaks – Perpetuals.com Ltd. (NASDAQ: PDC) Launches Joint AI Trading Research Group with European Institute of Management

Perpetuals.com (NASDAQ: PDC) and the European Institute of Management (“EIM”) launched a joint research group pairing more than 20 doctoral researchers with Perpetuals to develop AI-powered trading models combining machine learning and crowd intelligence. The researchers will have access to Perpetuals proprietary trading datasets and live venue data, with work focused on behavioral finance, trader performance classification, market microstructure and model risk. The initiative is expected to run for at least three years, with more than half of the participating researchers currently employed by Perpetuals. To view the full press release, visit https://ibn.fm/xSf7A About Perpetuals Perpetuals.com Ltd (NASDAQ: PDC) is a fintech company developing…

ThursdaySep 10, 2026 12:17 pm

QualityStocksNewsBreaks – Earth Science Tech Inc.’s (ETST) B2B-B2C Healthcare Platform Powers Continued Revenue Growth

Earth Science Tech (OTC: ETST) is positioning itself as a vertically integrated healthcare company through its subsidiaries RxCompoundStore, Mister Meds, and Peaks Curative, combining compounding pharmacy, telemedicine, clinical support, and fulfillment capabilities. Its B2B and B2C business model allows the company to serve independent clinics while also selling customized medications directly to consumers, creating diversified revenue streams across physical and digital healthcare operations. In FY2026, ETST reported revenue of $35.7 million, up from $33.1 million in FY2025 and $11.95 million in FY2024, while also reporting positive operating cash flow and a stronger balance sheet. The company reduced total liabilities from $3.146…

Site Search

Company Search